{
    "id": 27399,
    "fullName": "VEGFD positive",
    "impact": "unknown",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "VEGFD positive indicates the presence of the VEGFD gene, mRNA, and/or protein.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 2277,
        "geneSymbol": "VEGFD",
        "terms": [
            "VEGFD",
            "FIGF",
            "VEGF-D"
        ]
    },
    "variant": "positive",
    "createDate": "01/16/2018",
    "updateDate": "01/19/2018",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 12709,
            "approvalStatus": "Phase III",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a Phase III trial, Cyramza (ramucirumab) in combination with FOLFIRI chemotherapy improved overall survival (OS) by 2.4 months compared to placebo (13.9 vs 11.5 months) in colorectal cancer patients with high Vegfd level, while resulting in a decrease of OS (12.6 vs 13.1 months) in patients with low Vegfd level (PMID: 29228087; NCT01183780).",
            "molecularProfile": {
                "id": 28847,
                "profileName": "VEGFD positive"
            },
            "therapy": {
                "id": 2633,
                "therapyName": "Fluorouracil + Irinotecan + Leucovorin + Ramucirumab",
                "synonyms": "Ramucirumab + FOLFIRI"
            },
            "indication": {
                "id": 9256,
                "name": "colorectal cancer",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 10620,
                    "pubMedId": 29228087,
                    "title": "Analysis of angiogenesis biomarkers for ramucirumab efficacy in patients with metastatic colorectal cancer from RAISE, a global, randomized, double-blind, phase III study.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/29228087"
                }
            ],
            "ampCapAscoEvidenceLevel": "B",
            "ampCapAscoInferredTier": "I"
        }
    ],
    "molecularProfiles": [
        {
            "id": 28847,
            "profileName": "VEGFD positive",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}